Home » Newsletters » BioWorld Science

BioWorld Science

March 8, 2012

View Archived Issues

Novel kinase inhibitors patented

Fatty acid blocks HIV-1 infection in ex vivo cervical tissue model

HCV NS3 resistance variants detected after 7-day MK-5172 course

Strategic alliance aims to develop and commercialize new vaccines

Telormedix receives funding to develop Toll-like receptor 7 modulators

Abbott reports novel inhibitors of GlyT1

New sodium/glucose cotransporter 2 inhibitors developed in China

Roche discovers new HSL inhibitors

Scientists in Brazil identify new phosphodiesterase 5 inhibitors

Novel tablet for type 2 diabetes available in U.S. pharmacies

Horizon Pharma and Mundipharma amend commercialization agreement

Plant-derived lactic acid bacteria may help combat obesity

New anti-infectives designed at Merck & Co.

French company presents novel inhibitors of TNF-alpha

Antigen-specific MS therapy in phase I development

Mersana partners to develop novel antibody-drug conjugates

Courtagen and Avaxia join forces to create new assay

Sosei commences Japanese phase I study of antifungal

Exonhit receives E.U. grant for consortium work on predictive biomarkers

NME improves cognition in schizophrenia model

Alexza and Ferrer amend commercial partnership for Adasuve

ReGenx and Asklepios establish agreement for hemophilia A

Feraheme shows noninferiority to intravenous iron sucrose in iron deficiency anemia

KBP BioSciences reports new mineralocorticoid receptor antagonists

New diacylglycerol O-acyltransferase 1 inhibitors reported by Merck & Co.

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...